Identification of novel pro-alpha2(IX) collagen gene mutations in two families with distinctive oligo-epiphyseal forms of multiple epiphyseal dysplasia.

PubWeight™: 0.94‹?›

🔗 View Article (PMC 1378072)

Published in Am J Hum Genet on July 01, 1999

Authors

P Holden1, E G Canty, G R Mortier, B Zabel, J Spranger, A Carr, M E Grant, J A Loughlin, M D Briggs

Author Affiliations

1: Wellcome Trust Centre for Cell-Matrix Research, School of Biological Sciences, University of Manchester, Manchester, England, United Kingdom.

Articles citing this

Differential gene expression in ovarian carcinoma: identification of potential biomarkers. Am J Pathol (2004) 1.79

A mutation in COL9A1 causes multiple epiphyseal dysplasia: further evidence for locus heterogeneity. Am J Hum Genet (2001) 1.33

A new autosomal recessive form of Stickler syndrome is caused by a mutation in the COL9A1 gene. Am J Hum Genet (2006) 1.25

A mutation in the alpha 3 chain of type IX collagen causes autosomal dominant multiple epiphyseal dysplasia with mild myopathy. Proc Natl Acad Sci U S A (2000) 1.16

Pseudoachondroplasia and multiple epiphyseal dysplasia: a 7-year comprehensive analysis of the known disease genes identify novel and recurrent mutations and provides an accurate assessment of their relative contribution. Hum Mutat (2011) 1.13

Type IX collagen gene mutations can result in multiple epiphyseal dysplasia that is associated with osteochondritis dissecans and a mild myopathy. Am J Med Genet A (2010) 0.92

Intrafamilial phenotypic diversity in multiple epiphyseal dysplasia associated with a COL9A2 mutation (EDM2). Clin Rheumatol (2006) 0.90

Localisation of a gene for an autosomal recessive syndrome of macrocephaly, multiple epiphyseal dysplasia, and distinctive facies to chromosome 15q26. J Med Genet (2001) 0.86

COL9A2 and COL9A3 mutations in canine autosomal recessive oculoskeletal dysplasia. Mamm Genome (2010) 0.84

Genetics in osteoarthritis. Curr Genomics (2008) 0.80

Multiple epiphyseal dysplasia. Acta Orthop (2009) 0.75

Articles cited by this

Pseudoachondroplasia and multiple epiphyseal dysplasia due to mutations in the cartilage oligomeric matrix protein gene. Nat Genet (1995) 2.55

Ehlers-Danlos syndrome type IV: a single base substitution of the last nucleotide of exon 34 in COL3A1 leads to exon skipping. J Invest Dermatol (1995) 1.78

A mutation in the gene encoding the alpha 2 chain of the fibril-associated collagen IX, COL9A2, causes multiple epiphyseal dysplasia (EDM2). Nat Genet (1996) 1.47

Dysplasia epiphysialis multiplex; a report of fourteen cases in three families. J Bone Joint Surg Br (1955) 1.38

Multiple epiphysial dysplasia. Br Med J (1958) 1.35

Diverse mutations in the gene for cartilage oligomeric matrix protein in the pseudoachondroplasia-multiple epiphyseal dysplasia disease spectrum. Am J Hum Genet (1998) 1.33

G to T transversion at position +5 of a splice donor site causes skipping of the preceding exon in the type III procollagen transcripts of a patient with Ehlers-Danlos syndrome type IV. J Biol Chem (1991) 1.27

Dysplasia epiphysialis multiplex in three sisters. J Bone Joint Surg Br (1952) 1.25

An intron mutation in the human alpha 1(I) collagen gene alters the efficiency of pre-mRNA splicing and is associated with osteogenesis imperfecta type II. J Biol Chem (1990) 1.18

Genetic mapping of a locus for multiple epiphyseal dysplasia (EDM2) to a region of chromosome 1 containing a type IX collagen gene. Am J Hum Genet (1994) 1.12

Structure of the glycosaminoglycan domain in the type IX collagen-proteoglycan. Proc Natl Acad Sci U S A (1987) 1.11

Genetic linkage mapping of multiple epiphyseal dysplasia to the pericentromeric region of chromosome 19. Am J Hum Genet (1994) 1.04

Ehlers-Danlos syndrome type VIIA and VIIB result from splice-junction mutations or genomic deletions that involve exon 6 in the COL1A1 and COL1A2 genes of type I collagen. Am J Med Genet (1997) 1.03

Multiple epiphysial dysplasia. J Bone Joint Surg Br (1956) 1.02

Collagen IX. Int J Biochem Cell Biol (1997) 1.01

An RNA-splicing mutation (G+5IVS20) in the type II collagen gene (COL2A1) in a family with spondyloepiphyseal dysplasia congenita. Am J Hum Genet (1995) 0.99

Multiple epiphyseal dysplasia and pseudoachondroplasia due to novel mutations in the calmodulin-like repeats of cartilage oligomeric matrix protein. Clin Genet (1997) 0.96

Heterozygous mutation in the G+5 position of intron 33 of the pro-alpha 2(I) gene (COL1A2) that causes aberrant RNA splicing and lethal osteogenesis imperfecta. Use of carbodiimide methods that decrease the extent of DNA sequencing necessary to define an unusual mutation. J Biol Chem (1991) 0.95

The alpha 1 (IX) collagen gene gives rise to two different transcripts in both mouse embryonic and human fetal RNA. Proc Natl Acad Sci U S A (1990) 0.94

Multiple epiphyseal dysplasia, ribbing type: a novel point mutation in the COMP gene in a South African family. Am J Med Genet (1997) 0.92

Genetic heterogeneity in multiple epiphyseal dysplasia. Am J Hum Genet (1995) 0.92

A large family with multiple epiphyseal dysplasia linked to COL9A2 gene. Am J Med Genet (1998) 0.91

A 5' splice site mutation affecting the pre-mRNA splicing of two upstream exons in the collagen COL1A1 gene. Exon 8 skipping and altered definition of exon 7 generates truncated pro alpha 1(I) chains with a non-collagenous insertion destabilizing the triple helix. Biochem J (1994) 0.91

Human COL9A1 and COL9A2 genes. Two genes of 90 and 15 kb code for similar polypeptides of the same collagen molecule. Matrix Biol (1998) 0.91

Molecular cloning of the alpha 3 chain of human type IX collagen: linkage of the gene COL9A3 to chromosome 20q13.3. Genomics (1995) 0.89

Identification of five novel mutations in cartilage oligomeric matrix protein gene in pseudoachondroplasia and multiple epiphyseal dysplasia. Hum Mutat (1998) 0.89

Electron microscopical study in multiple epiphyseal dysplasia type II. Ultrastruct Pathol (1998) 0.79

Splice site mutation causing deletion of exon 21 sequences from the pro alpha 2(I) chain of type I collagen in a patient with severe dentinogenesis imperfecta but very mild osteogenesis imperfecta. Hum Mutat (1996) 0.77

Articles by these authors

LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development. Cell (2001) 11.99

Questionnaire on the perceptions of patients about total hip replacement. J Bone Joint Surg Br (1996) 7.44

Autosomal sex reversal and campomelic dysplasia are caused by mutations in and around the SRY-related gene SOX9. Cell (1994) 7.39

Questionnaire on the perceptions of patients about total knee replacement. J Bone Joint Surg Br (1998) 7.20

The roles of individual polyoma virus early proteins in oncogenic transformation. Nature (1982) 4.57

Imprint switching on human chromosome 15 may involve alternative transcripts of the SNRPN gene. Nat Genet (1996) 4.36

A controlled trial of zidovudine in primary human immunodeficiency virus infection. N Engl J Med (1995) 3.89

Cloning, sequencing and transcriptional control of the Schizosaccharomyces pombe cdc10 'start' gene. EMBO J (1985) 3.87

Questionnaire on the perceptions of patients about shoulder surgery. J Bone Joint Surg Br (1996) 3.72

Expression of the large T protein of polyoma virus promotes the establishment in culture of "normal" rodent fibroblast cell lines. Proc Natl Acad Sci U S A (1983) 3.65

Genetic characterization of human immunodeficiency virus type 1 in blood and genital secretions: evidence for viral compartmentalization and selection during sexual transmission. J Virol (1996) 3.48

Evidence-based recommendations for the role of exercise in the management of osteoarthritis of the hip or knee--the MOVE consensus. Rheumatology (Oxford) (2004) 3.38

Epidemiology of hip and knee pain and its impact on overall health status in older adults. Rheumatology (Oxford) (2004) 3.22

Mutations in LMX1B cause abnormal skeletal patterning and renal dysplasia in nail patella syndrome. Nat Genet (1998) 3.18

A short-term study of the safety, pharmacokinetics, and efficacy of ritonavir, an inhibitor of HIV-1 protease. European-Australian Collaborative Ritonavir Study Group. N Engl J Med (1995) 3.04

Vascular pericytes express osteogenic potential in vitro and in vivo. J Bone Miner Res (1998) 2.78

Regulation of chondrocyte differentiation by Cbfa1. Mech Dev (1999) 2.73

Pseudoachondroplasia and multiple epiphyseal dysplasia due to mutations in the cartilage oligomeric matrix protein gene. Nat Genet (1995) 2.55

Glucose/galactose malabsorption caused by a defect in the Na+/glucose cotransporter. Nature (1991) 2.45

Alterations in the immune response of human immunodeficiency virus (HIV)-infected subjects treated with an HIV-specific protease inhibitor, ritonavir. J Infect Dis (1996) 2.44

Design and cohort description of the InterAct Project: an examination of the interaction of genetic and lifestyle factors on the incidence of type 2 diabetes in the EPIC Study. Diabetologia (2011) 2.43

Recommendations for standardization and phenotype definitions in genetic studies of osteoarthritis: the TREAT-OA consortium. Osteoarthritis Cartilage (2010) 2.39

Effects of HIV disease on lipid, glucose and insulin levels: results from a large antiretroviral-naive cohort. HIV Med (2005) 2.33

Mutations in a new gene, encoding a zinc-finger protein, cause tricho-rhino-phalangeal syndrome type I. Nat Genet (2000) 2.23

The type II collagenopathies: a spectrum of chondrodysplasias. Eur J Pediatr (1994) 2.07

Prevalence and incidence of adults consulting for shoulder conditions in UK primary care; patterns of diagnosis and referral. Rheumatology (Oxford) (2005) 2.07

Metaphyseal chondrodysplasia, Schmid type. Clinical and radiographic delineation with a review of the literature. Pediatr Radiol (1988) 2.06

Errors of morphogenesis: concepts and terms. Recommendations of an international working group. J Pediatr (1982) 2.04

Duplication of ATR inhibits MyoD, induces aneuploidy and eliminates radiation-induced G1 arrest. Nat Genet (1998) 2.04

Nuclear localization of the protein encoded by the Wilms' tumor gene WT1 in embryonic and adult tissues. Development (1993) 2.02

Construction and functional characterization of polyomavirus genomes that separately encode the three early proteins. J Virol (1984) 2.02

The CALM1 core promoter polymorphism is not associated with hip osteoarthritis in a United Kingdom Caucasian population. Osteoarthritis Cartilage (2005) 1.99

Progressive pseudorheumatoid arthritis of childhood (PPAC). A hereditary disorder simulating rheumatoid arthritis. Eur J Pediatr (1983) 1.98

Guidelines for the identification, evaluation, and management of systemic hypertension in dogs and cats. J Vet Intern Med (2007) 1.95

Osteoporosis-pseudoglioma syndrome, a disorder affecting skeletal strength and vision, is assigned to chromosome region 11q12-13. Am J Hum Genet (1996) 1.89

Effects of matrix macromolecules on chondrocyte gene expression: synthesis of a low molecular weight collagen species by cells cultured within collagen gels. J Cell Biol (1982) 1.88

Evidence for coinfection by multiple strains of human immunodeficiency virus type 1 subtype B in an acute seroconvertor. J Virol (1995) 1.85

Genotypic and phenotypic spectrum in tricho-rhino-phalangeal syndrome types I and III. Am J Hum Genet (2000) 1.80

A dietary pattern protective against type 2 diabetes in the European Prospective Investigation into Cancer and Nutrition (EPIC)--Potsdam Study cohort. Diabetologia (2005) 1.79

The biosynthesis of procollagen. Essays Biochem (1976) 1.79

Malformations in newborn: results based on 30,940 infants and fetuses from the Mainz congenital birth defect monitoring system (1990-1998). Arch Gynecol Obstet (2002) 1.79

Identification and partial characterization of three low-molecular-weight collagenous polypeptides synthesized by chondrocytes cultured within collagen gels in the absence and in the presence of fibronectin. Biochem J (1983) 1.78

PAX8, a human paired box gene: isolation and expression in developing thyroid, kidney and Wilms' tumors. Development (1992) 1.77

Anaplastic Wilms' tumour, a subtype displaying poor prognosis, harbours p53 gene mutations. Nat Genet (1994) 1.76

Transcription of the cdc2 cell cycle control gene of the fission yeast Schizosaccharomyces pombe. EMBO J (1986) 1.73

Potent antiretroviral therapy of primary human immunodeficiency virus type 1 (HIV-1) infection: partial normalization of T lymphocyte subsets and limited reduction of HIV-1 DNA despite clearance of plasma viremia. J Infect Dis (1999) 1.70

A human keratin 14 "knockout": the absence of K14 leads to severe epidermolysis bullosa simplex and a function for an intermediate filament protein. Genes Dev (1994) 1.65

Mutations in the region encoding the von Willebrand factor A domain of matrilin-3 are associated with multiple epiphyseal dysplasia. Nat Genet (2001) 1.64

Cartilage oligomeric matrix protein interacts with type IX collagen, and disruptions to these interactions identify a pathogenetic mechanism in a bone dysplasia family. J Biol Chem (2000) 1.63

The biosynthesis of collagen. 1. N Engl J Med (1972) 1.61

Spondyloepiphyseal dysplasia. Birth Defects Orig Artic Ser (1974) 1.60

Comparison of measures to assess outcomes in total hip replacement surgery. Qual Health Care (1996) 1.60

Distribution of the matrix metalloproteinases stromelysin, gelatinases A and B, and collagenase in Crohn's disease and normal intestine. J Clin Pathol (1994) 1.60

A randomized, double-blind, placebo-controlled trial of glucosamine sulphate as an analgesic in osteoarthritis of the knee. Rheumatology (Oxford) (2002) 1.58

Insights into the genetic architecture of osteoarthritis from stage 1 of the arcOGEN study. Ann Rheum Dis (2010) 1.53

The biosynthesis of collagen. 3. N Engl J Med (1972) 1.52

Unified nomenclature for the COP9 signalosome and its subunits: an essential regulator of development. Trends Genet (2000) 1.51

Exon 10b of the NF1 gene represents a mutational hotspot and harbors a recurrent missense mutation Y489C associated with aberrant splicing. Genet Med (2001) 1.50

"New" dwarfing syndromes. Birth Defects Orig Artic Ser (1977) 1.49

Mutation analysis of LMX1B gene in nail-patella syndrome patients. Am J Hum Genet (1998) 1.49

Gangliosides expressed in human breast cancer. Cancer Res (1996) 1.49

Short rib-polydactyly (SRP) syndromes, types Majewski and Saldino-Noonan. Z Kinderheilkd (1974) 1.48

Manifestations and treatment of Schimke immuno-osseous dysplasia: 14 new cases and a review of the literature. Eur J Pediatr (2000) 1.48

The value of phenobarbital in the child who has had a single febrile seizure: a controlled prospective study. Pediatrics (1977) 1.46

Duplicate publication and related problems. Pediatrics (1990) 1.46

Type X collagen, a product of hypertrophic chondrocytes. Biochem J (1985) 1.45

The biosynthesis of basement membrane collagen in embryonic chick lens. I. Delay between the synthesis of polypeptide chains and the secretion of collagen by matrix-free cells. J Biol Chem (1972) 1.44

Further delineation of the 3-M syndrome with review of the literature. Am J Med Genet (1987) 1.43

Osteogenesis imperfecta: a clinical study of the first ten years of life. Calcif Tissue Int (1992) 1.43

The problem of open-sea navigation: the migration of the green turtle to ascension island. J Theor Biol (1969) 1.42

The assessment of shoulder instability. The development and validation of a questionnaire. J Bone Joint Surg Br (1999) 1.42

Patterns of viral dynamics during primary human immunodeficiency virus type 1 infection. The Sydney Primary HIV Infection Study Group. J Infect Dis (1998) 1.41

Mental retardation syndrome with renal concentration deficiency and intracerebral calcification. Eur J Pediatr (1990) 1.40

[Lipomucopolysaccharidosis, A new storage disease]. Z Kinderheilkd (1968) 1.38

If it's the virus, why aren't we measuring it? Med J Aust (1995) 1.38

A meta-analysis of nausea and vomiting following maintenance of anaesthesia with propofol or inhalational agents. Eur J Anaesthesiol (1998) 1.38

Regulation of glomerular basement membrane collagen expression by LMX1B contributes to renal disease in nail patella syndrome. Nat Genet (2001) 1.37

Transmission of triple-class, drug-resistant HIV-1 in Australia. Intern Med J (2010) 1.37

Macromolecular organization of chicken type X collagen in vitro. J Cell Biol (1991) 1.36

Hypochondroplasia: clinical and radiological aspects in 39 cases. Radiology (1979) 1.34

HIV lipodystrophy: prevalence, severity and correlates of risk in Australia. HIV Med (2003) 1.34

Diverse mutations in the gene for cartilage oligomeric matrix protein in the pseudoachondroplasia-multiple epiphyseal dysplasia disease spectrum. Am J Hum Genet (1998) 1.33

Primary total hip replacement surgery: a systematic review of outcomes and modelling of cost-effectiveness associated with different prostheses. Health Technol Assess (1998) 1.32

Distribution of type X collagen mRNA in normal and osteoarthritic human cartilage. Bone Miner (1991) 1.31

Kniest and Stickler dysplasia phenotypes caused by collagen type II gene (COL2A1) defect. Nat Genet (1993) 1.31

Isolation and ultrastructural analysis of microfibrillar structures from foetal bovine elastic tissues. Relative abundance and supramolecular architecture of type VI collagen assemblies and fibrillin. J Cell Sci (1991) 1.30

Missense mutations in the beta strands of the single A-domain of matrilin-3 result in multiple epiphyseal dysplasia. J Med Genet (2004) 1.30

Restoration of immunity to chronic hepatitis B infection in HIV-infected patient on protease inhibitor. Lancet (1997) 1.30

Characterization of three nef-defective human immunodeficiency virus type 1 strains associated with long-term nonprogression. Australian Long-Term Nonprogressor Study Group. J Virol (2000) 1.29

Recessively inherited multiple epiphyseal dysplasia with normal stature, club foot, and double layered patella caused by a DTDST mutation. J Med Genet (1999) 1.29

Functional characterization of human nucleosome assembly protein-2 (NAP1L4) suggests a role as a histone chaperone. Genomics (1997) 1.28

Increased frequency of CCR-5 delta 32 heterozygotes among long-term non-progressors with HIV-1 infection. The Australian Long-Term Non-Progressor Study Group. AIDS (1997) 1.27

Mucopolysaccharidosis. VII. Beta-glucuronidase deficiency. Humangenetik (1974) 1.26

The nature of the microfibrillar glycoproteins of elastic fibres. A biosynthetic study. Biochem J (1981) 1.25

The identification of glycoproteins associated with elastic-tissue microfibrils. Biochem J (1978) 1.25

A new familial intrauterine growth retardation syndrome the "3-M syndrome". Eur J Pediatr (1976) 1.24